Get the Stockscreener App
2.705
3.76%
-0.1057
After Hours:
2.71
0.005
+0.18%
Reshape Lifesciences Inc Stock (RSLS) Forecast
The Reshape Lifesciences Inc (RSLS) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $76.00, representing a +2,709% increase from the current price of $2.705. The highest analyst price target is $75.66, and the lowest is $76.33.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RSLS Price Target
Average 70.70
(+2,514% Upside)
Is Reshape Lifesciences Inc (RSLS) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 23.36 | Buy |
| STOCH(9,6) | 16.14 | Buy |
| STOCHRSI(14) | 5.396 | Buy |
| MACD(12,26) | -0.4875 | Sell |
| ADX(14) | 40.57 | Sell |
| William %R | -93.92 | Buy |
| CCI(14) | -89.48 | Neutral |
Buy: 4
Sell: 2
Neutral: 1
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.325
Sell
|
3.2718
Sell
|
| MA20 |
3.8951
Sell
|
3.6905
Sell
|
| MA50 |
4.457
Sell
|
4.3941
Sell
|
| MA100 |
5.083
Sell
|
5.4777
Sell
|
| MA200 |
8.0574
Sell
|
7.3678
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, RSLS could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 12 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on RSLS, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 23.36 indicates that RSLS is oversold. This indicates that RSLS price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 16.14 indicates that RSLS is oversold. This indicates that RSLS price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 5.396 indicates that RSLS is oversold. This suggests that RSLS price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 40.57 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -89.48 indicates that RSLS is still oversold but not to an extreme extent.
Long-term RSLS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Reshape Lifesciences Inc financial reports and earnings history, Reshape Lifesciences Inc (RSLS) stock could reach $63.83 by 2030, $782.50 by 2040 and $1,126.90 by 2050. See the projected annual prices until 2050 of the Reshape Lifesciences Inc stock below:
- Reshape Lifesciences Inc (RSLS) is expected to reach an average price of $357.16 in 2035, with a high prediction of $367.09 and a low estimate of $357.62. This indicates an $13,104% rise from the last recorded price of $2.705.
- Reshape Lifesciences Inc (RSLS) stock is projected to chart a bullish course in 2040, with an average price target of $794.00, representing an $29,253% surge from its current level. The forecast ranges from a conservative $5.5114 to a sky-high $782.50.
- Our analysts predict Reshape Lifesciences Inc (RSLS) to jump 16,604% by 2045, soaring from $452.24 to an average price of $451.83, potentially reaching $470.70. While $452.24 is the low estimate, the potential upside is significant.
- Reshape Lifesciences Inc (RSLS) stock is expected to climb by 2050, reaching an average of $1,107.78, a $40,853% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1,126.90 and $1,111.78, respectively, highlighting the market's uncertainty.
Reshape Lifesciences Inc Stock (RSLS) Year by Year Forecast
Reshape Lifesciences Inc Stock (RSLS) Price Forecast for 2025
Reshape Lifesciences Inc Stock (RSLS) is expected to reach an average price of $69.87 in 2025, with a high prediction of $77.57 and a low estimate of $62.17. This indicates an +2,483% rise from the last recorded price of $2.705.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| March, 2025 | $73.53 | $76.33 | $75.66 | +2,618% |
| April, 2025 | $76.55 | $70.07 | $71.61 | +2,730% |
| May, 2025 | $76.62 | $77.52 | $77.57 | +2,733% |
| June, 2025 | $76.63 | $76.19 | $74.15 | +2,733% |
| July, 2025 | $77.86 | $78.38 | $76.41 | +2,779% |
| August, 2025 | $78.03 | $76.73 | $75.54 | +2,785% |
| September, 2025 | $73.85 | $74.87 | $74.14 | +2,630% |
| October, 2025 | $76.79 | $73.63 | $72.80 | +2,739% |
| November, 2025 | $73.97 | $73.97 | $73.92 | +2,634% |
| December, 2025 | $67.95 | $68.52 | $72.22 | +2,412% |
Reshape Lifesciences Inc Stock (RSLS) Price Forecast for 2026
The predicted value for Reshape Lifesciences Inc (RSLS) in 2026 is set at an average of $45.67. Estimates vary from a peak of $66.25 to a trough of $25.09, indicating an +1,588% surge from the present price of $2.705.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $66.74 | $66.67 | $66.25 | +2,367% |
| February, 2026 | $63.42 | $63.84 | $65.29 | +2,245% |
| March, 2026 | $61.45 | $61.52 | $62.63 | +2,172% |
| April, 2026 | $56.80 | $56.88 | $60.07 | +2,000% |
| May, 2026 | $52.89 | $52.91 | $55.42 | +1,855% |
| June, 2026 | $49.76 | $49.79 | $51.80 | +1,740% |
| July, 2026 | $45.18 | $45.28 | $48.67 | +1,570% |
| August, 2026 | $41.53 | $41.68 | $44.18 | +1,435% |
| September, 2026 | $37.15 | $37.19 | $40.55 | +1,274% |
| October, 2026 | $33.73 | $33.78 | $36.15 | +1,147% |
| November, 2026 | $29.91 | $29.93 | $32.73 | +1,006% |
| December, 2026 | $25.09 | $25.09 | $28.92 | +827.49% |
Reshape Lifesciences Inc Stock (RSLS) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Reshape Lifesciences Inc (RSLS) is $94.67, with a high forecast of $188.36 and a low forecast of $0.9742. This indicates an +3,400% increase from the last price of $2.705.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $21.20 | $21.21 | $24.06 | +683.79% |
| February, 2027 | $17.38 | $17.38 | $20.21 | +542.35% |
| March, 2027 | $12.59 | $12.59 | $16.40 | +365.44% |
| April, 2027 | $8.7116 | $8.7128 | $11.60 | +222.06% |
| May, 2027 | $4.8395 | $4.8441 | $7.7155 | +78.91% |
| June, 2027 | $158.67 | $0.9742 | $147.17 | +5,766% |
| July, 2027 | $147.93 | $149.36 | $134.30 | +5,369% |
| August, 2027 | $158.19 | $160.49 | $152.37 | +5,748% |
| September, 2027 | $156.51 | $157.95 | $150.75 | +5,686% |
| October, 2027 | $183.77 | $157.08 | $180.77 | +6,694% |
| November, 2027 | $177.53 | $184.03 | $181.40 | +6,463% |
| December, 2027 | $199.86 | $180.10 | $188.36 | +7,288% |
Reshape Lifesciences Inc Stock (RSLS) Price Forecast for 2028
In 2028, Reshape Lifesciences Inc (RSLS) is projected to reach an average price of $179.65, with a high projection of $199.49 and a low estimate of $159.81. This indicates an +6,541% rise from the last price of $2.705.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $199.12 | $203.12 | $199.49 | +7,261% |
| February, 2028 | $199.88 | $198.18 | $197.38 | +7,289% |
| March, 2028 | $185.20 | $185.64 | $197.94 | +6,747% |
| April, 2028 | $191.71 | $181.33 | $186.90 | +6,987% |
| May, 2028 | $174.26 | $185.32 | $190.96 | +6,342% |
| June, 2028 | $186.12 | $181.50 | $183.56 | +6,781% |
| July, 2028 | $181.63 | $182.25 | $184.16 | +6,615% |
| August, 2028 | $178.59 | $178.88 | $176.75 | +6,502% |
| September, 2028 | $172.39 | $173.39 | $175.26 | +6,273% |
| October, 2028 | $169.07 | $170.15 | $168.83 | +6,150% |
| November, 2028 | $160.48 | $160.87 | $165.17 | +5,833% |
| December, 2028 | $158.97 | $159.81 | $158.11 | +5,777% |
Reshape Lifesciences Inc Stock (RSLS) Price Forecast for 2029
The 2029 price forecast for Reshape Lifesciences Inc Stock (RSLS) is $111.11 on average, with a high prediction of $156.30 and a low estimate of $65.92. This represents an +4,008% increase from the previous price of $2.705.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $150.32 | $151.56 | $156.30 | +5,457% |
| February, 2029 | $141.46 | $141.96 | $144.08 | +5,129% |
| March, 2029 | $136.59 | $137.76 | $139.25 | +4,949% |
| April, 2029 | $130.50 | $130.65 | $134.26 | +4,724% |
| May, 2029 | $121.47 | $121.60 | $128.58 | +4,391% |
| June, 2029 | $114.05 | $114.11 | $118.14 | +4,116% |
| July, 2029 | $106.17 | $106.32 | $111.83 | +3,825% |
| August, 2029 | $97.58 | $97.66 | $104.17 | +3,507% |
| September, 2029 | $89.86 | $89.88 | $95.42 | +3,222% |
| October, 2029 | $80.67 | $80.68 | $87.83 | +2,882% |
| November, 2029 | $73.27 | $73.29 | $78.71 | +2,609% |
| December, 2029 | $65.91 | $65.92 | $71.28 | +2,336% |
Reshape Lifesciences Inc Stock (RSLS) Price Forecast for 2030
Reshape Lifesciences Inc Stock (RSLS) is expected to reach an average price of $162.63 in 2030, with a high forecast of $323.16 and a low forecast of $2.1085. This signifies an +5,912% surge from the last price of $2.705.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $56.21 | $56.23 | $63.83 | +1,978% |
| February, 2030 | $48.46 | $48.49 | $54.26 | +1,691% |
| March, 2030 | $40.74 | $40.75 | $46.18 | +1,406% |
| April, 2030 | $33.02 | $33.02 | $38.73 | +1,121% |
| May, 2030 | $23.38 | $23.41 | $31.08 | +764.50% |
| June, 2030 | $15.63 | $15.65 | $21.44 | +477.76% |
| July, 2030 | $5.9687 | $5.9734 | $13.68 | +120.65% |
| August, 2030 | $317.10 | $2.1085 | $306.00 | +11,623% |
| September, 2030 | $313.49 | $304.89 | $297.49 | +11,489% |
| October, 2030 | $290.97 | $316.18 | $304.43 | +10,657% |
| November, 2030 | $299.86 | $302.36 | $293.86 | +10,986% |
| December, 2030 | $329.76 | $315.96 | $323.16 | +12,091% |
0.38%
1.34%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):